The UWCCC proposes to have available for its members Protocol Specific Research support for pilot clinical/translational research studies that would benefit from timely funding. The UWCCC has a long history of funding pilot studies that have led to more timely clinical research and NCI funding. The UWCCC has funded 15 (8 of these ongoing or recently initiated) early phase pilot clinical studies over the last grant period with an accrual of 173 subjects. Efficient accrual to UWCCC-supported studies is enhanced by the UWCCC-supported statewide clinical trials network (Wisconsin Oncology Network). This method of support allows investigators with emerging ideas or promising initial pilot data to apply for the support of a research nurse and data manager to conduct high priority, innovative, feasibility and early stage institutional clinical research protocols. Proposals will be requested twice yearly and will undergo peer-review (under the direction of Associate Directors H. Bailey and P. Sondel) with selection based on scientific merit, need for Protocol Specific Research funding, potential to lead to NCI funding, and UWCCC research priorities. Once selected, protocols receive research nurse/data management support from this mechanism and all the necessary developmental and regulatory support via the Oncore database for UWCCC-required monitoring and reporting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-37
Application #
8068003
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
37
Fiscal Year
2010
Total Cost
$138,729
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ferreira, Carolina A; Ni, Dalong; Rosenkrans, Zachary T et al. (2018) Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res 11:4955-4984
Ehlerding, Emily B; Ferreira, Carolina A; Aluicio-Sarduy, Eduardo et al. (2018) 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Mol Pharm 15:2606-2613
Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET? Eur J Nucl Med Mol Imaging :
Zhang, Fan; Braun, Doug R; Ananiev, Gene E et al. (2018) Biemamides A-E, Inhibitors of the TGF-? Pathway That Block the Epithelial to Mesenchymal Transition. Org Lett 20:5529-5532
Deming, Dustin A (2018) Tailoring the colorectal cancer disease assessment to the treatment strategy. Gut 67:996-997
Aluicio-Sarduy, Eduardo; Ellison, Paul A; Barnhart, Todd E et al. (2018) PET radiometals for antibody labeling. J Labelled Comp Radiopharm 61:636-651
Slosarek, Erin L; Schuh, Amber L; Pustova, Iryna et al. (2018) Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon Fasciculation. Cell Rep 24:2248-2260
Tomko, Lucas A; Hill, Ryan C; Barrett, Alexander et al. (2018) Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Sci Rep 8:12941
Saghiri, Mohammad Ali; Asatourian, Armen; Sheibani, Nader (2018) Angiogenesis and the prevention of alveolar osteitis: a review study. J Korean Assoc Oral Maxillofac Surg 44:93-102
Pandhi, Nancy; Kraft, Sally; Berkson, Stephanie et al. (2018) Developing primary care teams prepared to improve quality: a mixed-methods evaluation and lessons learned from implementing a microsystems approach. BMC Health Serv Res 18:847

Showing the most recent 10 out of 1528 publications